Unknown NA INTERVENTIONAL 2-arm NCT02648399

Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma

Sponsor: Fujian Medical University

Interventions surgery：BCND（bilateral central lymph node dissection） surgery：UCND（unilateral central lymph node dissection）

Updated 6 times since 2017 Last updated: Jan 6, 2016 Started: Dec 31, 2015 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02648399, this NA trial focuses on Thyroid Papillary Carcinoma and remains ongoing. Sponsored by Fujian Medical University, it has been updated 6 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fujian Medical University

Data source: Fujian Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fuzhou, China